These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 25604824)

  • 1. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
    Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
    Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
    Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
    Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent arterial inflammation during the apparent remission state of Takayasu's arteritis. What do cytokines tell us?
    Savioli B; Salu BR; de Brito MV; Vilela Oliva ML; de Souza AWS
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):33-39. PubMed ID: 29600943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 and Th1 T-cell responses in giant cell arteritis.
    Deng J; Younge BR; Olshen RA; Goronzy JJ; Weyand CM
    Circulation; 2010 Feb; 121(7):906-15. PubMed ID: 20142449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of IL-6 in the pathogenesis of Takayasu arteritis.
    Kong X; Sun Y; Ma L; Chen H; Wei L; Wu W; Ji Z; Ma L; Zhang Z; Zhang Z; Zhao Z; Hou J; Dai S; Yang C; Jiang L
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S21-7. PubMed ID: 26633132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
    Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
    Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    Rheumatology (Oxford); 2013 Feb; 52(2):352-62. PubMed ID: 23065314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.
    Geri G; Terrier B; Rosenzwajg M; Wechsler B; Touzot M; Seilhean D; Tran TA; Bodaghi B; Musset L; Soumelis V; Klatzmann D; Cacoub P; Saadoun D
    J Allergy Clin Immunol; 2011 Sep; 128(3):655-64. PubMed ID: 21724243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.
    Espígol-Frigolé G; Planas-Rigol E; Lozano E; Corbera-Bellalta M; Terrades-García N; Prieto-González S; García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC
    Front Immunol; 2018; 9():809. PubMed ID: 29731755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector CD4+ T-cell subsets in Takayasu arteritis-differences between the peripheral blood and the aorta.
    Savioli B; Torquato HFV; Paredes-Gamero EJ; Franco AFDV; Gigek CO; Artigiani Neto R; de Souza AWS
    Clin Exp Immunol; 2024 Jul; 217(2):183-194. PubMed ID: 38766690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E; Cosan F; Cefle A; Deniz G
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of Th lymphocyte subsets in patients with Behcet disease].
    Liang L; Wang H; Peng XY; Zhao M
    Zhonghua Yan Ke Za Zhi; 2011 May; 47(5):393-7. PubMed ID: 21756739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
    Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
    Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.
    Pan LL; Du J; Gao N; Liao H; Wan J; Ci WP; Yang C; Wang T
    Clin Rheumatol; 2016 Dec; 35(12):3031-3036. PubMed ID: 27629397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.